Figure 5.
Drug biodistribution (percentage of injected dose/g of tissue) of doxorubicin (DOX) or aspartate-modified DOX (Asp-DOX) in mice bearing the LAT1-positive cell lines HCT116 (a) and HepG2 (b), and the LAT1-negative cell line H1299 (c) (n = 3–5 per group) (*P < 0.05).